Farheen Makani
Psychiatric/Mental Health · San Antonio, TXNPI 1013420595
Payments from drug & device makers
Across 45 payments — averaging $19.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$212
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$160
- Supernus Pharmaceuticals, Inc.$115
- Sunovion Pharmaceuticals Inc.$111
- Otsuka America Pharmaceutical, Inc.$90
- Takeda Pharmaceuticals U.S.A., Inc.$50
- plus $154 from 5 others
What the payments were for
- Food & beverage$84595%
- Education$475%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 10 | $212 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $160 |
| Supernus Pharmaceuticals, Inc. | 6 | $115 |
| Sunovion Pharmaceuticals Inc. | 6 | $111 |
| Otsuka America Pharmaceutical, Inc. | 5 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| OWP Pharmaceuticals, Inc. | 2 | $40 |
| Bausch Health US, LLC | 2 | $40 |
| Adlon Therapeutics L.p. | 2 | $27 |
| Eisai Inc. | 2 | $25 |
| Lundbeck LLC | 1 | $22 |
How this compares
$892 in reported general payments places this provider in the 55th percentile of 2,724 psychiatric/mental health providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 25 | $10,181 |
| Duloxetine Hcl | 35 | $909 |
| Oxcarbazepine | 14 | $507 |
| Bupropion Hcl SrBupropion Hcl | 27 | $229 |
| Aripiprazole | 16 | $194 |
| Gabapentin | 14 | $190 |
| Hydroxyzine Pamoate | 11 | $177 |
| Buspirone Hcl | 22 | $170 |
| Lithium Carbonate | 18 | $153 |
| Lamotrigine | 18 | $152 |
| Risperidone | 18 | $143 |
| Quetiapine Fumarate | 23 | $138 |
| Sertraline Hcl | 14 | $124 |
| Trazodone Hcl | 13 | $56 |
| Escitalopram Oxalate | 14 | $55 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in San Antonio
- Monique GonzalezSan Antonio$126K
- Geoffrey GonzalesSan Antonio$57K
- Sara Koenig LangstonSan Antonio$27K
- Peter TorciviaSan Antonio$13K
- Tracy HicksLongview$684K
- Natalie TellezHouston$602K
- Karah BrashierRichardson$567K
- Grant DavisRichardson$360K
- Victor IlogEl Paso$167K
- Lisa ShamblinGrapevine$163K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.